387 related articles for article (PubMed ID: 8567042)
1. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
van Paassen P; de Zeeuw D; Navis G; de Jong PE
Hypertension; 1996 Feb; 27(2):202-8. PubMed ID: 8567042
[TBL] [Abstract][Full Text] [Related]
2. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
van Paassen P; de Zeeuw D; de Jong PE
J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
[TBL] [Abstract][Full Text] [Related]
3. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
van Paassen P; Navis GJ; De Jong PE; De Zeeuw D
Eur J Clin Invest; 1999 Dec; 29(12):1019-26. PubMed ID: 10583449
[TBL] [Abstract][Full Text] [Related]
5. Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
van Paassen P; de Zeeuw D; Navis G; de Jong PE
Nephrol Dial Transplant; 2000 May; 15(5):637-43. PubMed ID: 10809804
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
7. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
8. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
[TBL] [Abstract][Full Text] [Related]
9. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
[TBL] [Abstract][Full Text] [Related]
10. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
Parfrey PS; Markandu ND; Roulston JE; Jones BE; Jones JC; MacGregor GA
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):94-7. PubMed ID: 6789950
[TBL] [Abstract][Full Text] [Related]
11. Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake.
Lopes de Faria JB; Friedman R; de Cosmo S; Dodds RA; Mortton JJ; Viberti GC
Nephron; 1997; 76(4):411-7. PubMed ID: 9274838
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men.
Price DA; De'Oliveira JM; Fisher ND; Hollenberg NK
Hypertension; 1997 Aug; 30(2 Pt 1):240-6. PubMed ID: 9260987
[TBL] [Abstract][Full Text] [Related]
13. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
14. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men.
Ilson BE; Boike SC; Martin DE; Freed MI; Zariffa N; Jorkasky DK
Clin Pharmacol Ther; 1998 Apr; 63(4):471-81. PubMed ID: 9585802
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibition improves pressure natriuresis in essential hypertension.
Paassen PV; Zeeuw D; Jong PE; Navis G
J Am Soc Nephrol; 2000 Oct; 11(10):1813-1818. PubMed ID: 11004211
[TBL] [Abstract][Full Text] [Related]
16. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
[TBL] [Abstract][Full Text] [Related]
17. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
van Twist DJ; Houben AJ; de Haan MW; Mostard GJ; Kroon AA; de Leeuw PW
Hypertension; 2013 Oct; 62(4):789-93. PubMed ID: 23918750
[TBL] [Abstract][Full Text] [Related]
19. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
